Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non-Current Debt: 2018-2019

Historic Non-Current Debt for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $32.0 million.

  • EyePoint Pharmaceuticals' Non-Current Debt rose 148.65% to $32.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $32.0 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $17.3 million for FY2018, which is N/A change from last year.
  • EyePoint Pharmaceuticals' Non-Current Debt amounted to $32.0 million in Q1 2019, which was up 81.33% from $17.6 million recorded in Q4 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Non-Current Debt peaked at $32.0 million during Q1 2019, and registered a low of $12.8 million during Q1 2018.
  • In the last 2 years, EyePoint Pharmaceuticals' Non-Current Debt had a median value of $17.5 million in 2018 and averaged $19.4 million.
  • Data for EyePoint Pharmaceuticals' Non-Current Debt shows a peak YoY skyrocketed of 148.65% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows EyePoint Pharmaceuticals' Non-Current Debt stood at $17.6 million in 2018, then surged by 148.65% to $32.0 million in 2019.
  • Its last three reported values are $32.0 million in Q1 2019, $17.6 million for Q4 2018, and $17.5 million during Q3 2018.